15/07/2025
Desiree Lyon, co-founder of the American Porphyria Foundation (APF) is one of the pioneers of the 1983 Orphan Drug Act, incentivising the development of treatments for rare diseases.
Her work with the APF has allowed for further awareness of porphyria amongst healthcare professionals, leading to better outcomes for patients.
It is a privilege for CLINUVEL to support the APF’s mission to empower people living with porphyria and increase access to treatment options.